March 2003

|
Volume 15 Issue 4
Design and protocol of CURE. CURE is a large trial involving 12,562 patients with non-ST elevation acute coronary syndrome with either positive biomarkers myocardial injury or new ECG changes.1 The trial thus involves at least a moderate-risk group o…
Approximately 1.42 million patients are admitted every year to hospitals in the United States with unstable angina and non-ST-segment elevation myocardial infarction (UA/NSTEMI). Over the past several years, advances in the evaluation and management…
Defining the anatomy. A randomized study published in the Journal of the American College of Cardiology last year involved low-risk patients who underwent stress testing and coronary angiography.1 Naturally, it found that coronary angiograms detected…
CASE #1 Jeffrey Popma, MD I prepared several case presentations because I wanted to use the panel assembled here this evening to tell me how to take care of my patients when I return home. You will all therefore be interrogated on how to best treat…
CASE #3 Jeffrey Popma, MD Let me begin by talking about our new catheterization laboratory table that accommodate patients up to 600 lbs. Everyone should get one of these tables because it will allow you to receive some incredible patient referrals…
The P3 Summit meeting was held in Washington, D.C. on September 23, 2002 and was designed to provide an opportunity to discuss the substantial volume of new data that have emerged on the subject of platelet inhibition post-PCI. The presentations and…
When examining the diffuse nature of coronary disease, it is important to recognize the fact that acute coronary syndromes are just the tip of the atherothrombotic “iceberg” (Figure 1). That is, they are the events which are clinically manifested as…
History of aspirin. Although aspirin’s active ingredient has been used for medicinal purposes for centuries, there is still much we don’t know about it. In fact, the first published research is from 1763 entitled “An Account of the Success of the Bar…